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Abstract
Background
Trachoma is endemic in several Pacific Island states. Recent surveys across the Solomon
Islands indicated that whilst trachomatous inflammation—follicular (TF) was present at lev-
els warranting intervention, the prevalence of trachomatous trichiasis (TT) was low. We set
out to determine the relationship between chlamydial infection and trachoma in this
population.
Methods
We conducted a population-based trachoma prevalence survey of 3674 individuals from
two Solomon Islands provinces. Participants were examined for clinical signs of trachoma.
Conjunctival swabs were collected from all children aged 1–9 years. We tested swabs for
Chlamydia trachomatis (Ct) DNA using droplet digital PCR. Chlamydial DNA from positive
swabs was enriched and sequenced for use in phylogenetic analysis.
Results
We observed a moderate prevalence of TF in children aged 1–9 years (n = 296/1135,
26.1%) but low prevalence of trachomatous inflammation—intense (TI) (n = 2/1135, 0.2%)
and current Ct infection (n = 13/1002, 1.3%) in children aged 1–9 years, and TT in those
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aged 15+ years (n = 2/2061, 0.1%). Ten of 13 (76.9%) cases of infection were in persons
with TF or TI (p = 0.0005). Sequence analysis of the Ct-positive samples yielded 5/13 (38%)
complete (>95% coverage of reference) genome sequences, and 8/13 complete plasmid
sequences. Complete sequences all aligned most closely to ocular serovar reference
strains.
Discussion
The low prevalence of TT, TI and Ct infection that we observed are incongruent with the
high proportion of children exhibiting signs of TF. TF is present at levels that apparently war-
rant intervention, but the scarcity of other signs of trachoma indicates the phenotype is mild
and may not pose a significant public health threat. Our data suggest that, whilst conjuncti-
val Ct infection appears to be present in the region, it is present at levels that are unlikely to
be the dominant driving force for TF in the population. This could be one reason for the low
prevalence of TT observed during the study.
Author Summary
Trachoma is the most common infectious cause blindness worldwide, and the target of a
global elimination initiative. A package of community-wide interventions is recommended
to treat trachoma, which aim to reduce transmission of the causative agent Chlamydia tra-
chomatis. These interventions require significant, prolonged investment. Clinical observa-
tion of follicles on the underside of the eyelid is used to assess requirement for and success
of intervention. However, we now know that there are nonchlamydial causes of these folli-
cles, so the observation of this clinical sign may not be specific for chlamydial infection. A
recent study showed that infection testing can be cost-effective in low infection prevalence
settings, as the money spent on infection testing is more than offset by the savings from
avoiding additional rounds of community-wide interventions. We show here that, despite
a high prevalence of clinical signs of disease, the estimated prevalence of chlamydial infec-
tion is low. The prevalence of the sight-threatening end stage of disease is also low, so we
must consider whether the costly community-wide interventions are appropriate in this
setting. The use of molecular tools at the population level to guide trachoma policy is still
under investigation; this study will contribute to the pool of data required to assess the util-
ity of these tools.
Introduction
Trachoma, caused by ocular strains of Chlamydia trachomatis (Ct), is the leading infectious
cause of blindness worldwide [1]. Ocular infection with Ct is associated with a characteristic
follicular conjunctivitis, known as “trachomatous inflammation—follicular” (TF) [2], which
can persist for some time after the initiating infection has been cleared. In some individuals,
infection can also cause the sign “trachomatous inflammation—intense” (TI). Repeated and
prolonged bouts of severe inflammatory disease can lead to trachomatous scarring [3] (TS)
which, in some individuals, can eventually cause the eyelashes to turn inwards, producing tra-
chomatous trichiasis (TT), a condition in which the lashes painfully abrade the cornea. In com-
bination with other trachoma-induced changes to the ocular surface, this may lead to corneal
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opacity (CO) and blindness [2,4]. In 2014, the World Health Organization (WHO) estimated
trachoma to be a public health problem in 51 countries, and responsible for approximately 2.2
million cases of visual impairment. Efforts to globally eliminate the disease as a public health
problem are promising, with several countries having reported reaching elimination goals [1].
The island states of the Western Pacific Region are made up of several thousand widely dis-
persed volcanic islands and coral atolls. It has long been suspected that trachoma is endemic in
these islands, with reports from the early twentieth century indicating that trachoma was pres-
ent [5–9]. More recently, trachoma rapid assessments (TRA) conducted in the Pacific indicated
the presence of trachoma in Fiji, Vanuatu, Solomon Islands, Nauru and Kiribati. Although
TRAs do not give accurate estimates of disease prevalence, the TRA data suggested that, whilst
TF levels appeared high, both TI and TT were surprisingly scarce [10].
A population-based prevalence survey (PBPS) is the gold standard for estimating district-
wide trachoma burden [11] and trachoma PBPSs took place between 2011 and 2014 in some
districts of the Solomon Islands, Kiribati and Fiji [12]. They reported that TF prevalence was
above the WHO-recommended threshold (10% TF in children aged 1–9 years) for public
health interventions in the Melanesian-dominated districts studied (Solomon Islands and Fiji).
Those surveys also reported surprisingly low levels of TT [12,13] (at or below the WHO elimi-
nation threshold of 0.1% in the all-ages population[14]) compared to those observed in other
populations with highly prevalent TF [15,16].
The seemingly discrepant (with respect to out-of-region comparators) finding of high prev-
alence of TF in populations with negligible levels of TI or TT led us to question whether ocular
Ct infections are present in Melanesia. We augmented GTMP mapping of Temotu and Rennell
and Bellona provinces in the Solomon Islands, with tests for infection and next-generation
sequencing, to determine the prevalence of Ct, and whether Ct and active trachoma were asso-
ciated. If Ct was detected in conjunctival specimens, we considered whether those strains were
of an ocular or genital genotype. We considered how our results compare to other published
datasets.
Methods
Ethics statement
The study adhered to the tenets of the Declaration of Helsinki. The London School of Hygiene
& Tropical Medicine Ethics Committee (6319 and 6360) and the Solomon Islands National
Health Research and Ethics Committee (HRC13/18) granted ethical approval for this study.
Village and household heads were consulted prior to enrolment. Individuals were informed
of the nature and requirements of the study prior to enrolment, by a staff member fluent in
local dialects, and were asked to provide written evidence of consent. For those aged 18 years
and under, written consent of a parent or guardian was required.
Study design
Our study was conducted alongside GTMP survey teams as they undertook mapping of one
evaluation unit (EU) in the Solomon Islands in October and November, 2013. In the GTMP
study, an EU was defined as a single administrative province, however, Temotu and Rennell
and Bellona were grouped together into a single EU due to their small populations. Local
healthcare workers identified Temotu and Rennell and Bellona as the provinces with the high-
est suspected trachoma burden in the country. The study was a cross-sectional cluster-rando-
mised PBPS of trachoma. We determined a priori that 1019 children aged 1–9 years should be
sampled to estimate infection prevalence of 10% with a precision of ±3% at the 95% confidence
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level, assuming a design effect of 2.65 [17]. Our sample size was framed around the population
of children in this age range, as they are the group most likely to harbour infection [15,18].
The Land Registry listed 533 villages across the two provinces in 2013. Local healthcare
workers identified villages that were not currently inhabited, and remaining villages were eligi-
ble for simple random selection. In each cluster a targeted number of households were ran-
domly selected from a full list of village households to recruit the required number of children.
All household residents over the age of 1 year in each selected household were eligible for inclu-
sion [17].
Clinical examination and photography
Clinical examination was conducted by graders who had been certified according to GTMP
protocols [17]. Clinical grading was carried out using the WHO simplified system, in which tri-
chiasis is defined as at least one eyelash in contact with the eyeball (or evidence of recent
removal of in-turned eyelashes), TF is defined as 5 or more follicles of>0.5mm diameter on
the central part of the upper tarsal conjunctiva, and TI is defined as pronounced inflammatory
thickening of the upper tarsal conjunctiva obscuring>50% of the deep tarsal vessels [2].
Conjunctival photographs were taken using a Nikon D3000 SLR camera and graded by an
independent photograder who had previously had a kappa agreement score in excess of 0.9
when grading photographs also graded by a master grader. The photograder was masked to the
corresponding field grade for each photograph.
Clinical sample collection, handling and processing
Conjunctival swabs were collected from all children aged 1–9 years. Polyester-coated cotton
swabs (Puritan Medical Products, Guilford, ME, USA) were passed three times over the right
tarsal conjunctiva with a 120° turn in between each pass [19–21]. The examiner changed their
gloves between participants to avoid cross contamination in the field. 1 in 30 swabs did not
touch the conjunctiva but were passed within 15 cm of a seated participant then stored and
processed in identical fashion to other study specimens, to act as field contamination controls.
Swabs were stored immediately in RNAlater (Life Technologies, Paisley, UK), kept on ice
packs in the field before short-term storage at 4°C, and frozen within 48 hours of collection
[22]. Specimens were transported to the UK on dry ice where they were stored at -80°C until
they were extracted with Qiagen AllPrep DNA/RNAmini kits (Qiagen, Manchester, UK)
according to manufacturer’s recommendations.
Droplet digital PCR
DNA specimens were tested for the Ct plasmid using a droplet digital PCR assay targeting a
single Ct plasmid target in duplex with a human ribonuclease gene, which acted as endogenous
control. The published assay methodology was used [23] with minor protocol adjustments to
the tested sample volume (4.95μL increased to 8μL) and oligonucleotide concentrations
(primer concentration increased from 300nM to 900nM; probe concentration decreased from
300nM to 200nM). Samples were considered valid if there was>95% confidence in non-zero
endogenous control concentration, and positive according to published criteria (>95% confi-
dence in non-zero chlamydial plasmid load [23]). Samples from children with TF were retested
with an alternative, quantitative assay targeting both chlamydial chromosomal and plasmid
targets [24]. The oligonucleotides used are shown in Table 1.
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Chlamydial genome and plasmid sequencing
Chlamydial DNA was preferentially enriched in clinical samples using custom Ct-specific RNA
baits in a SureSelect system, as developed by the PATHSEEK consortium. Due to the low bio-
mass of conjunctival swabs, human carrier DNA was added to achieve the required DNA input
concentration for sequencing. Samples were sequenced on the Illumina MiSeq platform [25].
Literature search
Articles were identified through two specific literature searches to illustrate how our data com-
pared to existing published studies. PubMed hits, references contained within those articles
and relevant articles from the authors’ own archives were considered eligible for inclusion.
Using the terms “population-based” and “trachoma”, we identified population-level studies
where TF had been reported in children aged 1–9 years and TT had been reported in adults
over the age of 15 years in the same population. District-level data were extracted where more
than a single district was reported on in a single publication. Using the search terms “tra-
choma” and “infection”, we identified studies reporting population-level nucleic acid-based
infection data alongside clinical data on TF (with or without TI). Data from communities who
had received one or more rounds of MDA were excluded. During both literature searches,
studies where age-specific trachoma prevalence in 1- or 2-year age bands was presented were
also reviewed.
Data recording and analysis
Field data were recorded using a purpose-built Open Data Kit (https://opendatakit.org/) app
[17]. Age adjustments were carried out using 5-year census age bands [26]. All analyses were
carried out using R version 3.2.2 [27]. The overall agreement between field exam and photo-
graphic grade was determined using kappa agreement scores. The relationship between TF and
Ct infection was tested using logistic regression. Ct loads in children with and without TF were
compared using the MannWhitney U test.
Following preliminary assessment of mapping quality to various Ct strains, 251-bp paired
end reads were trimmed and mapped to Ct reference strain AHAR-13 genome sequence (Gen-
Bank accession CP000051.1) and B/Jali20 plasmid genome sequence (FM865436.1) using
Table 1. Oligonucleotides used in this study. Chlamydial targets adapted for ddPCR [23,24] based on sequences from Pickett and colleagues [87].
Endogenous control target adapted from Luo and colleagues [88].
Target Oligo Sequence (5ʹ to 3ʹ)
Chlamydia trachomatis omcB Primer (F) GACACCAAAGCGAAAGACAACAC
Primer (R) ACTCATGAACCGGAGCAACCT
Probe FAM**-CCACAGCAAAGAGACTCCCGTAGACCG-BHQ1
Chlamydia trachomatis plasmid ORF2 Primer (F) CAGCTTGTAGTCCTGCTTGAGAGA
Primer (R) CAAGAGTACATCGGTCAACGAAGA
Probe FAM*/HEX**-CCCCACCATTTTTCCGGAGCGA-BHQ1
Homo sapiens RPP30 Primer (F) AGATTTGGACCTGCGAGCG
Primer (R) GAGCGGCTGTCTCCACAAGT
Probe HEX*-TTCTGACCTGAAGGCTCTGCGCG-BHQ1
F: forward; R: reverse; BHQ: Black Hole Quencher; omcB: outer membrane protein complex B; ORF: open reading frame; RPP30: ribonuclease P/MRP
30kDa subunit
*Diagnostic assay [23]
**Quantitative assay [24]
doi:10.1371/journal.pntd.0004863.t001
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Bowtie 2 [28]. SAMtools and BCFtools were used to index and assemble reads, and bases were
called by collapsing reads vertically [29]. Trimmed reads were also mapped to E/Bour (genome
HE601870.1, plasmid HE603212.1) to determine whether the choice of reference influenced
branching points in the phylogram.
Consensus sequences were submitted for megablast search on National Centre for Biotech-
nology Information (NCBI) GenBank to determine nearest relatives based on genetic sequence.
Whole genomes were aligned with progressiveMauve [30]. A core alignment was generated by
extraction and amalgamation of locally collinear blocks using stripSubsetLCBs [31]. Distance
matrices and bootstrapped phylogeny was inferred using phangorn, ape and SeqinR packages
in R [32–34]. Regions orthologous to ompA, trpA and the plasticity zone (PZ; a ~20 kb region
of the Ct chromosome between dsbB and ycfV [35]) were analysed in isolation due to their dis-
proportionately high variability and influence on pathogenicity compared to the rest of the Ct
chromosome. These were extracted from consensus sequences using BLASTn in the NCBI
BLAST+ suite, and aligned using MUSCLE alignment software [36].
Results
Enrolment and disease prevalence
The combined population of Temotu (21,362), and Rennell and Bellona (3041) comprises
4.7% (24,403/515,870) of the total population of the Solomon Islands, according to the 2009
national census [26]. We surveyed 959 households in 32 clusters throughout this EU. 4049 peo-
ple were enumerated, and 3674 (91%) consented to participate (a total of 17% of the provincial
population, average 4.2 people per household). Data was not collected on the reasons people
did not take part. The examined population included 1135 children aged 1–9 years (53% male),
and 2061 adults aged 15 years and over (42% male). The median age was 18 years (min 1, max
100, inter-quartile range [IQR]: 8–38 years). In this population there were 397 (10.9%) cases of
TF, 5 (0.1%) cases of TI, and 2 (0.1%) cases of trichiasis in either eye of subjects of all ages iden-
tified by field grading. 84% of cases of TF were bilateral.
In children aged 1–9 years, the prevalence of active trachoma (defined as presence of TF
and/or TI in either eye) was 26.3% (TF: 26.1% [296/1135]; TI: 0.2% [2/1135]). The proportion
of males in this age group with active trachoma was significantly higher than that of females in
the same age group (28.9% [176/608] versus 23.1% [122/527], p = 0.027). When adjusted for
age and sex, the prevalence of active trachoma was 22% (95% confidence interval [CI]: 18.5–
26.0%). In adults aged 15 years and over, the prevalence of active trachoma was 1.2% (TF: 1%
[21/2061]; TI: 0.1% [3/2061]). The prevalence of trichiasis in adults was 0.1% (2/2061). When
adjusted for age and sex, the prevalence of TT was 0.04% (95% CI: 0–0.3%). The field team did
not recall one case of trichiasis and the other was documented as mild, with a single lash con-
tacting the globe away from the cornea.
Photographs were taken from 3110/3674 (85%) of participants. Preliminary quality control
yielded 2418 (78%) photographs that were unsuitable for grading due to quality issues. A total
of 692 photographs from study participants of all ages (238 in children aged 1–9 years) were
evaluated by an independent grader. Photo-grading according to the simplified grading system
agreed with TF in 94% of cases leading to Fleiss’ kappa agreement scores of 0.88, which indi-
cated excellent agreement between photo grader and field grading in TF calls. Cases of TS were
noticed in the photo set, although the evidence was insufficient to determine the population
prevalence of this sign.
Fig 1 shows exemplars of both mild and more severe TF in Solomon Island children, as well
as a normal conjunctiva for contrast. The age-specific prevalence of TF cases is shown in Fig 2.
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Conjunctival infection
Swabs were collected from 1076/1135 (94.8%) child participants aged 1–9 years, along with 41
field controls. Of those, 1002 (93.1%) passed quality control by testing positive for the
Fig 1. Photographs of conjunctivae showing (A) no evidence of active trachoma, (B) mild trachomatous inflammation-follicular (TF) and (C) more severe TF.
All three photographs were taken of conjunctival C. trachomatis infection-negative children aged 1–9 resident in Temotu, Rennell or Bellona, Solomon
Islands, October-November 2013, in whom the photo grade and field grade matched.
doi:10.1371/journal.pntd.0004863.g001
Fig 2. Age-specific prevalence (grey bars) and 95% confidence interval (arrows) of trachomatous inflammation—follicular (TF) in
individuals aged 1–15 years, recorded during a trachoma survey of Temotu, Rennell and Bellona, Solomon Islands, October-November
2013.
doi:10.1371/journal.pntd.0004863.g002
Trachoma in the Outer Solomon Islands
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004863 September 7, 2016 7 / 21
endogenous control gene H. sapiens RPP30. All blank field controls and all known-negative
extraction and PCR controls tested negative for endogenous control and microbial targets. Evi-
dence of Ct infection was found in 13 (1.3%) of 1002 specimens. Of those who tested positive
for plasmid on diagnostic screen, 9 also tested positive for Ct chromosomal target omcB.
Of the individuals whose swab was positive for the endogenous control RPP30, 257/1002
(25.7%) had TF and/or TI in the right eye (Table 2). The prevalence of Ct infection was 10/257
(3.9%) in those with TF and/or TI, and 3/745 (0.4%) in those without. Active disease status was
highly significantly associated with current infection (odds ratio: 10.0, p = 0.0005).
While TF was observed in all 32 villages that were surveyed, we observed Ct infection in just
eight villages. While the study was not designed to detect sub-EU-level differences in preva-
lence, post hoc analysis indicated there were significantly more cases of infection per capita in
Rennell and Bellona than in Temotu province (6/131 [4.6%] versus 7/871 [0.8%], respectively;
MannWhitney U: p = 0.0004). TF levels in the 1–9 year old indicator group were in excess of
10% in both provinces included in the EU, but significantly lower in Rennell and Bellona
(27.3% in Temotu versus 17.2% in Rennell and Bellona; Mann Whitney U: p = 0.0001).
Load of infection
The mean load of endogenous control target was 12,560 copies/swab (IQR: 872–13,980 copies/
swab). In positive swabs, the median load of Ct plasmid was 13,840 copies/swab (IQR: 3599–
84,990 copies/swab). There was a large difference in median load between Ct positive samples
from children with active disease when compared to those without active disease, although the
difference was not statistically significant (median 13,840 versus 782 copies/swab; MannWhit-
ney U test p = 0.81). The median omcB load was 7725 copies/swab (IQR: 1696–22,110 copies/
swab) and the mean plasmid:genome ratio (i.e., plasmid copy number per bacterium) was 4.4
(IQR: 3.7–5.6) which is similar to that described elsewhere [24].
Genome sequencing
Sequencing was successful in 11/13 strains. The mean number of paired reads per specimen
was 2.3 million (IQR: 2.1–2.7 million; Table 3). The median percentage of reads mapping to A/
HAR-13 reference genome was 10.1% (IQR: 1.5–24.4%) per specimen. The median percentage
of reads mapping to B/Jali20/OT reference plasmid was 2.1% (IQR: 0.3–4.8%) per specimen.
Complete genome sequences (>95% coverage) were obtained from five of 13 specimens,
whilst partial genome sequences (<95% coverage) were obtained from six specimens. Com-
plete (>95%) or partial (<95%) plasmid sequences were obtained from eight and three speci-
mens, respectively. One specimen failed to sequence. The median coverage of at least 1× read
depth of the reference genome was 51.5% (IQR: 12.4–98.2%); the median coverage of at least
1× of the reference plasmid was 99% (IQR: 61.4–99.7%).
Table 2. Frequency of conjunctivalC. trachomatis infection and active trachoma during a trachoma
survey in Temotu, Rennell and Bellona, Solomon Islands, October-November 2013.
ddPCR result No TF/TI (%) TF/TI (%) Total
Positive 3 (0.4) 10 (3.9) 13 (1.3)
Negative 742 (99.6) 247 (96.1) 989 (98.7)
Total 745 257 1002 (100)
ddPCR: droplet digital polymerase chain reaction; TF: trachomatous inﬂammation—follicular; TI:
trachomatous inﬂammation—intense.
doi:10.1371/journal.pntd.0004863.t002
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BLASTn analysis of five complete Solomon Islands Ct consensus genome sequences against
archived Ct genome sequences revealed that all five had closest sequence homology and align-
ment to serovar A type ocular strains. BLASTn analysis of eight complete Solomon Islands
plasmid consensus sequences revealed highest sequence homology with published serovar B
ocular strain plasmids.
Phylogenetic analysis of the complete Solomon Islands Ct genomes showed that these sam-
ples formed a single clade of closely related genotypes that formed a sub-clade of the ocular
strains. The five complete genomes were more closely related to each other than they were to
the nearest reference neighbour (A/HAR-13). Strains from the Solomon Islands were most
closely related to the ocular serovars in the T2 chlamydial clade, as shown in Fig 3. Bootstrap-
ping supported our phylogram by indicating resampling did not alter the branch position in
>80% of bootstrap runs.
Outer membrane protein A (ompA) sequences from the ocular reference strains do not clus-
ter in a single clade, as has been described previously [37]. OmpA orthologs from the five Solo-
mon Island sequences were more closely related to each other than to their nearest neighbour
which was the C-TW3 strain. Their relationship to other reference sequences is shown in S2A
Fig. Additionally, tryptophan synthase alpha subunit (trpA) orthologs in Solomon Island
sequences were most similar to ocular strains (S2B Fig) and featured a single nucleotide
Table 3. Sequencing parameters and results of BLASTn analysis of consensus sequence. Conjunctival C. trachomatis genomes obtained from
Temotu, Rennell and Bellona, Solomon Islands, in October-November 2013.
Sample Genetic
component
Total paired
reads
Number of paired reads mapped to
reference (%)
% reference
covered*
Serovar of closest NCBI BLASTn
match
SB000209 Genome 1,948,968 445 (0.02) 0.2 F
Plasmid 173 (0.01) 15.5 D
SB002563 Genome 1,838,502 513 (< 0.01) 0.5 I
Plasmid 35 (< 0.01) 12.4 F
SB002739 Genome 2,530,443 403,672 (16.0) 95.8 A
Plasmid 61,345 (2.4) 99.7 B
SB006908 Genome 2,594,512 34,663 (1.3) 18.5 J
Plasmid 3857 (0.1) 76.7 D
SB006930 Genome 2,630,055 1,743,718 (66.3) 98.9 A
Plasmid 293,102 (11.1) 99.8 B
SB008107 Genome 2,269,697 485,840 (21.4) 98.0 A
Plasmid 79,314 (3.5) 99.8 B
SB011363 Genome 3,878,711 75,326 (1.9) 16.3 I
Plasmid 17,375 (0.4) 99.2 B
SB011759 Genome 3,044,398 52,165 (1.7) 16.3 A
Plasmid 11,707 (0.4) 96.0 B
SB011836 Genome 313 0 (0) 0.0 -
Plasmid 0 (0) 0.0 -
SB012441 Genome 2,996,613 301,482 (10.1) 84.5 A
Plasmid 63,827 (2.1) 99.5 B
SB013112 Genome 2,274,168 1,345,864 (59.2) 98.9 A
Plasmid 332,462 (14.6) 99.8 B
SB013321 Genome 2,128,740 584,834 (27.5) 98.8 A
Plasmid 127,976 (6.0) 98.8 B
* At least 1× read depth
doi:10.1371/journal.pntd.0004863.t003
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deletion leading to a premature stop codon and truncation of the open reading frame when
compared to urogenital sequences. Finally, the relationship between the plasticity zone (PZ) of
Solomon Island sequences compared to references was evaluated and is shown in supplemen-
tary Fig 2C.
Fig 3. Maximum likelihood phylogram of (A) genome and (B) plasmid sequences from clinical specimens collected in the Solomon Islands in October and
November 2013, assembled toC. trachomatis A/HAR-13 and B/Jali20/OT reference, respectively. All branches had bootstrap values over 85/100.
doi:10.1371/journal.pntd.0004863.g003
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Literature search
A low prevalence of TT has been observed in other populations in which TF was highly preva-
lent. Fig 4 shows data taken from published PBPSs in Nigeria [38–44], Niger [45], Sudan [46],
Kenya [16], Ethiopia [47] and Cameroon [48,49] comparing the prevalence of TF in those aged
1–9 years with the prevalence of TT in 15+ year-olds in the same EUs, all of which were treat-
ment-naïve. Of 58 identified EUs with comparable prevalence of TF in the 1–9 year olds (10%
< TF< 40%) to that observed in the current study, 50% had a TT prevalence greater than 1%
in those over the age of 15 years; the median TT prevalence was 1%, compared to 0.1% in our
survey. Our population had a high TF prevalence when compared to other districts in this anal-
ysis with<1% TT.
Published data from studies in Ethiopia [50], Niger [50], Tanzania [18], Gambia [18], Cam-
eroon [48], Mali [51] and Brazil [52] indicate that in other trachoma-endemic populations, the
highest age-specific TF prevalence is generally in those aged 3–4 years. When published age-
specific TF profiles from other parts of the world are compared to the age distribution in this
study (Fig 5), the peak age-specific TF prevalence in our data is shown to be in an older age
group.
We identified a number of previous studies have reported concomitant Ct infection and
active trachoma prevalence estimates [19–21,53–70] in children aged 0–9 years or a subset of
that group in 35 districts. At the population level there is a good correlation between the two
(R = 0.84) (Fig 6). Our Ct infection estimate does not conform to the patterns observed in
those other populations, with infection being substantially less prevalent than might be
expected given the TF prevalence.
Discussion
We report an apparently mild trachoma phenotype in which TF is moderately prevalent yet Ct
infection, TI and TT are rare. The findings reflect those of other studies; over 2300 adults were
Fig 4. Comparison of unadjusted prevalence of trachomatous trichiasis (TT) in 15+ year olds, and
trachomatous inflammation—follicular (TF) in 1–9 year-olds, in treatment-naïve trachoma-endemic EUs for
which data have previously been published (n = 58), and in which the TF prevalence in 1–9 year-olds was
10–40%.Correlation coefficient (R) is 0.40 for this subset, but 0.77 if including studies from areas of any
prevalence.
doi:10.1371/journal.pntd.0004863.g004
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surveyed in Makira, Isabel and Central provinces yet only 3 cases of TT identified, indicating
an unadjusted prevalence among those adults of 0.1% despite 22.2% of the 1–9 years popula-
tion in the same survey having signs of TF [12]. The TF prevalence in Temotu, Rennell and
Bellona is the highest of the populations surveyed during GTMP mapping. Choiseul province
had low levels of both TF (6%) and TT (0%). Interestingly, Western Province had more TT
cases than Temotu, Rennell and Bellona [71]. Further studies are warranted to determine
whether infection prevalence is also higher in that region. The prevalence of TF in these com-
munities qualifies this EU for priority implementation of the A, F and E components of the
SAFE strategy (surgery to treat TT, mass antibiotic distribution to treat infection, promotion of
facial cleanliness and environmental improvement to reduce transmission [72]), but the trichi-
asis data suggest the elimination target for TT has already been met. The evidence of this survey
suggests that prevalence of TF in children may not be an appropriate marker of disease burden
in this setting. Prolonged infection with Ct, intense transmission of Ct, presence of TI and
other markers of inflammation have been associated with progression to TS [3,73–75], the pre-
cursor of TT. It is therefore feasible that the low prevalence of TI and Ct are related to the pau-
city of TT in this population.
In Fig 4 we demonstrate that the correlation between reported TF and TT prevalence is
weak, suggesting that high TF prevalence is not always indicative of a significant TT burden.
This is not an unexpected finding; the signs of TF are transient, being instigated and cleared
Fig 5. Published age-specific trachomatous inflammation—follicular (TF) prevalence data in studies undertaken in districts with >10%
TF in overall child population (dotted and dashed lines), compared to the same in Temotu, Rennell and Bellona, Solomon Islands,
October-November 2013 (grey columns).
doi:10.1371/journal.pntd.0004863.g005
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over the course of weeks or months, whereas TT has a much longer-term onset and is influ-
enced by an accumulation of a lifetime of microbiological and immunological stimuli. Field
grading has not previously been standardised across studies and must therefore be compared
between studies with caution. TF is used in part for ease and uniformity of field grading rather
than specificity for chlamydial infection, and Fig 6 shows that there is a moderate correlation
between population Ct infection prevalence and population TF prevalence in most districts
studied to date. The search criteria for this literature search were relatively lenient; controlling
for field grading discrepancy, sample collection methodology, and diagnostic test would likely
result in a stronger correlation.
At the individual level, TF and Ct prevalence do not always correlate well; for example in a
rural Tanzanian community where the TF prevalence was>10%, only 6.1% of those with TF
had Ct infection and no association was found with clinical signs disease [74]. Follicular
inflammation of the conjunctiva can have many different causes, such as viruses, nonchlamy-
dial bacteria, chemical exposure and allergic reactions [76]. While detailed eyelid examination
may be able to distinguish these infections phenotypically, the WHO simplified grading system
is not sufficiently detailed to do so. Streptococcus pneumoniae and Haemophilus influenzae
have been shown to be significantly associated with TF in the Gambia and Tanzania [74,77].
Numerous other species of the Staphylococcus, Streptococus,Moraxella,Hameophilus and Cor-
ynebacteria genera among others have been cultured from the conjunctivae of children and
adults living in trachoma-endemic areas. Although many have not been shown to associate
with clinical signs of TF, there are indications that in adults these bacteria can drive
Fig 6. Relationship between the prevalence of conjunctival C. trachomatis infection (diagnosed by nucleic acid amplification test) and
trachomatous inflammation—follicular (TF) in the total 0–9 year-old population or a subset of that group at the district level (n = 35
districts).Correlation coefficient (R) is 0.84.
doi:10.1371/journal.pntd.0004863.g006
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inflammation which leads to increased scar tissue deposition [78] or recurrent TT after surgery
[79,80]. It is therefore likely that a proportion of all TF cases globally may not be chlamydial in
origin; it seems that in this Pacific Island setting, this proportion is high and this is translated
into a reduced prevalence of end-stage trachomatous disease. Fig 4 also indicates that this may
also be true of other parts of the world, where districts with sufficient TF to qualify for inter-
vention under WHO guidelines do not necessarily have a significant TT burden. Exposure to
circulating Ctmay modulate the immune response at the conjunctiva to increase inflammation
in response to otherwise commensal organisms. In turn this could drive the immunopathology
that leads to scarring. It is possible that the low prevalence of Ct observed in this population is
insufficient to drive intense transmission, and children are exposed less frequently than in
other trachoma-endemic populations and therefore are not as susceptible to such intense or
regular periods of inflammation.
The highest age-specific TF prevalence in this study was in those aged 6 years (Fig 1). The
difference between that and other published data, as documented in Fig 5, may imply a differ-
ent mode or intensity of transmission, or may reflect reduced accumulation of partial immu-
nity. It is not possible to determine the true mechanism without intensive longitudinal study,
but this observation supports the case that the epidemiology of TF in our population is
atypical.
While the majority of our Ct-positive swabs were taken from eyes with active trachoma, we
consider the low absolute number of infections insufficient to drive the moderate burden of
TF. It is not clear from our cross-sectional study whether a non-chlamydial microbial agent is
causing TF, or whether those with TF had suffered a relatively recent Ct infection and had per-
sistent inflammatory disease causing the follicular inflammation we observed. The use of
ddPCR has not yet become widespread in infectious disease studies. While it is not suitable for
all applications, it offers the significant benefit of reference-free quantification of nucleic acids.
In the present study, the load of Ct in positive samples was substantial, which are thought to be
more transmissible than low-load infection. There was also substantially higher infection load
in those with TF as compared to those without TF, although this difference was not statistically
significant.
Despite recent advances in culture-free sequence methodologies, low-load infections are
known to yield poor quality or no sequence data. The technique we used in this study report-
edly provides high quality sequence data (20× read depth over at least 95% of the genome)
when the input specimen has above ~12,000 and ~98,000 chlamydial genome copies in vaginal
swab and urine samples, respectively [25]. A lower load limit for ensuring high quality
sequencing in ocular samples is not yet known, but we were encouraged that partial or com-
plete sequence data were yielded from 11/13 Ct positive swabs strains that were sequenced.
Those where complete genome coverage (>95%) was achieved appeared to be most closely
related to ocular serovars, and appeared to be very closely related to each other. The sequence
information suggested that, at trpA and the wider PZ, the Solomon sequences were closely
related to ocular strains, and ocular and urogenital strains were distinct from each other at
these loci. The trpA open reading frame was truncated in these sequences. This region contains
key determinants of Ct tissue tropism and further supports the close relationship of these
strains to classical ocular references. The small number of sequences available makes it difficult
to identify differences potentially related to pathogenicity. Urogenital strains are known to be
able to infect conjunctival epithelium [81], and given the high prevalence of sexually transmit-
ted Ct infections in the Solomon Islands [82], we may have expected some contamination of
the conjunctivae with urogenital chlamydial strains. Our data did indicate urogenital strains
were present in several conjunctivae, but the quality of those sequences aligning to urogenital
references was uniformly low. It is not possible to determine whether this was because these
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were urogenital strains that had not established a sufficiently fulminant infection to yield
enough material for sequencing, or whether the matches obtained were an artefact of the low
sequence coverage. We can say, though, that our next generation sequencing confirmed that
strains with high sequence homology to well-defined ocular Ct strains are present in the con-
junctivae of children in the Solomon Islands.
One limitation of our study is the absence of an alternative explanation for the discrepancy
between Ct and TF levels. Only samples for which testing passed various quality control steps
were included in this paper and our test had been previously validated against an external stan-
dard. We therefore do not believe that simple diagnostic failure has significantly influenced our
data. Of the four signs of trachoma described in this paper (TF, TI, TT and current infection),
three (infection, TI and TT) are present at low levels in this population. Further studies are
underway to test for potential alternative pathogens such as S. pneumoniae andH. influenzae,
and we are investigating longer-term markers of Ct infection by screening the population of
Temotu, Rennell and Bellona for both trachomatous scarring and antibodies against chlamyd-
ial pgp3 antigens. We have not addressed the genetics of the population in this study and while
host genetic factors have been shown to associate with an increased risk of scarring [83,84]
very little is known about diversity in immune response genes in the Solomon Islands. The lim-
ited amounts of immunogenetic typing data that are available indicate that some HLA epitopes
associated with increased risk of scarring (e.g. HLA-C2) are moderately prevalent in the Pacific
region, while other putative protective alleles (e.g. the HLA-B08:01~C03:04 haplotype) are
almost absent (data taken from allelefrequencies.net, search March 2016). Investigating this is
beyond the scope of this study, but accumulated evidence on the genetics of trachoma indicate
that both pathogen and host are sufficiently well adapted to coexistence that a host polymor-
phism that makes the host entirely refractory, or pathogen variation that completely amelio-
rates the infectivity and/or pathogenicity of Ct seems unlikely. Polymorphisms in key immune
genes such as IL-10 and gamma-interferon have been shown to be more frequent in cases with
severe trachoma than in normal controls [85], although these were not replicated in genome-
wide association screening. It is possible that variation in immune responsiveness may influ-
ence the susceptibility of this population to Ct infection but a specific immune pathway that is
expressed significantly differently between those in whom scarring progresses and those in
whom it doesn’t has yet to be identified [75].
In addition to ocular Ct infection, we observed signs of both active trachoma and trachoma-
tous conjunctival scarring in this sample indicating trachoma is or has recently been endemic
in these islands. However, the prevalence of Ct infection appeared to be too low to be the sole
explanation for the high burden of TF, while TI and TT were curiously scarce given the sub-
stantial amount of TF that was present. Whilst Ctmay account for some of the TF in this popu-
lation, we expect that the majority of TF-like disease is either caused by a single as-yet
undetermined factor, or by multiple contributory aetiologies. This form of disease, if not
unique to the Solomon Islands, might inflate estimates of trachoma burden and could lead to
unwarranted mass drug administration in other world populations. In several European set-
tings, there has been a steady increase in incidence and reinfection rates of urogenital Ct despite
enhanced detection and treatment, which some have hypothesised could be attributed to inter-
ruption of the natural acquisition of immunity [86]. We do not have good markers of what
constitutes ‘acquired immunity to Ct’ to measure this, but it is relevant in this context to con-
sider the possibility of negative effects of MDA in addition to the potential positive ones. The
findings of this study may have profound impacts on approaches to trachoma programme
monitoring in the peri-elimination period.
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